Search

Author/Creator Holkova, Beata

1. A phase 1 study of bortezomib and romidepsin in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma, indolent B-cell lymphoma, peripheral T-cell lymphoma, or cutaneous T-cell lymphoma. Issue 6 (3rd June 2017)

Authors:
Holkova, Beata; Yazbeck, Victor; Kmieciak, Maciej; Bose, Prithviraj; Ma, Shuo; Kimball, Amy; Tombes, Mary Beth; Shrader, Ellen; Wan, Wen; Weir-Wiggins, Caryn; Singh, Amanda; Hogan, Kevin T.; Conine, Sarah; Sankala, Heidi; Roberts, John D.; Shea, Thomas C.; Grant, Steven
Journal:
Leukemia & lymphoma
Issue:
Volume 58:Issue 6(2017)
Page Start:
1349
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Phase 1 study of belinostat (PXD-101) and bortezomib (Velcade, PS-341) in patients with relapsed or refractory acute leukemia and myelodysplastic syndrome. Issue 5 (16th April 2021)

Authors:
Holkova, Beata; Shafer, Danielle; Yazbeck, Victor; Dave, Sandeep; Bose, Prithviraj; Tombes, Mary Beth; Shrader, Ellen; Wan, Wen; Bandyopadhyay, Dipankar; Weir, Caryn; Collins, Elizabeth B.; Garnett, Amanda; Kmieciak, Maciej; Roberts, John D.; Garcia-Manero, Guillermo; Grant, Steven
Journal:
Leukemia & lymphoma
Issue:
Volume 62:Issue 5(2021)
Page Start:
1187
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomas. Issue 3 (3rd March 2016)

Authors:
Holkova, Beata; Kmieciak, Maciej; Bose, Prithviraj; Yazbeck, Victor Y.; Barr, Paul M.; Tombes, Mary Beth; Shrader, Ellen; Weir-Wiggins, Caryn; Rollins, April D.; Cebula, Erin M.; Pierce, Emily; Herr, Megan; Sankala, Heidi; Hogan, Kevin T.; Wan, Wen; Feng, Changyong; Peterson, Derick R.; Fisher, R...
Journal:
Leukemia & lymphoma
Issue:
Volume 57:Issue 3(2016:Mar.)
Page Start:
635
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Phase 1 trial of ibrutinib and carfilzomib combination therapy for relapsed or relapsed and refractory multiple myeloma. Issue 11 (2nd November 2018)

Authors:
Chari, Ajai; Larson, Sarah; Holkova, Beata; Cornell, Robert F.; Gasparetto, Cristina; Karanes, Chatchada; Matous, Jeffrey V.; Niesvizky, Ruben; Valent, Jason; Lunning, Matthew; Usmani, Saad Z.; Anderson, Larry D.; Chang, Lipo; Lee, Yihua; Pak, Yvonne; Salman, Zeena; Graef, Thorsten; Bilotti, Eliz...
Journal:
Leukemia & lymphoma
Issue:
Volume 59:Issue 11(2018)
Page Start:
2588
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗